Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Care for Cryptococcal Antigenemia
NCT07743593Phase 3Not yet recruiting
- Sponsor
- University of Minnesota
- Start
- Jan 2027
- Primary completion
- Aug 2031
- Countries
- 1
01
Overview
A Phase 3 trial of fluconazole, sponsored by University of Minnesota. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
fluconazole
Beyond the preview
Go deeper on NCT07743593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07743593.